Cargando…
Targeting TPX2 Suppresses the Tumorigenesis of Hepatocellular Carcinoma Cells Resulting in Arrested Mitotic Phase Progression and Increased Genomic Instability
Hepatocellular carcinoma (HCC) remains one of the most difficult cancers to treat, with chemotherapies being relatively ineffective. Therefore, a better knowledge of molecular hepatocarcinogenesis will provide opportunities for designing targeted therapies. TPX2 (targeting protein for Xklp2) is over...
Autores principales: | Hsu, Chao-Wen, Chen, Yu-Chia, Su, Hsing-Hao, Huang, Guan-Jin, Shu, Chih-Wen, Wu, Tony Tong-Lin, Pan, Hung-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479243/ https://www.ncbi.nlm.nih.gov/pubmed/28638452 http://dx.doi.org/10.7150/jca.17478 |
Ejemplares similares
-
Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer
por: Pan, Hung-Wei, et al.
Publicado: (2017) -
Targeting DTL induces cell cycle arrest and senescence and suppresses cell growth and colony formation through TPX2 inhibition in human hepatocellular carcinoma cells
por: Chen, Yu-Chia, et al.
Publicado: (2018) -
CDK5-mediated phosphorylation and stabilization of TPX2 promotes hepatocellular tumorigenesis
por: Wang, Fuqiang, et al.
Publicado: (2019) -
Costunolide causes mitotic arrest and enhances radiosensitivity in human hepatocellular carcinoma cells
por: Liu, Chia-Yuan, et al.
Publicado: (2011) -
p53 Suppresses Structural Chromosome Instability Following Mitotic Arrest In Human Cells
por: Dalton, W. Brian, et al.
Publicado: (2010)